Mar 07, 2022 / 04:10PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good morning, and welcome once again. We are here with the top management of GlaxoSmithKline at Cowen's 42nd Annual Healthcare Conference. We're very, very pleased to have with us Dr. Hal Barron, who is Chief Scientific Officer and President of Research and Development. Dr. Barron has shown over the last 30 or so years that he's clearly one of the industry's most prolific drug development experts. So it's always great to have conversations with him.
Questions and Answers:
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystSo Hal, thanks again for your time this morning. I'd like to start out and ask, what have -- do you believe, have been your greatest accomplishments in R&D since joining GSK a little over 4 years ago?
Hal V. Barron - GlaxoSmithKline plc - Chief Scientific Officer, President of R&D and Director
Yes. Thanks, Steve. Thanks for having me. I